Press release
April 20, 2026
Spruce Biosciences Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Spruce Biosciences, Inc. (SPRB)
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Apr. 20, 2026-- Spruce Biosciences, Inc. (“Spruce Biosciences”) (NASDAQ: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today